Canlyniadau Chwilio - Eric F. Morand

Mireinio'r Canlyniadau
  1. 1
    New therapeutic target in inflammatory disease: macrophage migration inhibitory factor

    New therapeutic target in inflammatory disease: macrophage migration inhibitory factor gan Eric F. Morand

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations

    Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations gan Eric F. Morand

    Cyhoeddwyd 2002
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    It hasn’t gone away: the problem of glucocorticoid use in lupus remains

    It hasn’t gone away: the problem of glucocorticoid use in lupus remains gan Diane Apostolopoulos, Eric F. Morand

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus

    BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus gan Fabien B. Vincent, Eric F. Morand, Fabienne Mackay

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    The BAFF/APRIL system in SLE pathogenesis

    The BAFF/APRIL system in SLE pathogenesis gan Fabien B. Vincent, Eric F. Morand, Pascal Schneider, Fabienne Mackay

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    OP0001 The lupus low disease activity state (LLDAS) definition discriminates responders in a systemic lupus erythematosus (SLE) trial: post-hoc analysis of the phase iib muse trial of anifrolumab

    OP0001 The lupus low disease activity state (LLDAS) definition discriminates responders in a systemic lupus erythematosus (SLE) trial: post-hoc analysis of the phase iib muse trial... gan Eric F. Morand, Anna Berglind, T Sheytanova, Raj Tummala, G. Illei

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study

    Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythem... gan Worawit Louthrenoo, Nuntana Kasitanon, Eric F. Morand, Rangi Kandane‐Rathnayake

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Annexin-1 Regulates Macrophage IL-6 and TNF via Glucocorticoid-Induced Leucine Zipper

    Annexin-1 Regulates Macrophage IL-6 and TNF via Glucocorticoid-Induced Leucine Zipper gan Yuan Yang, Daniel Aeberli, April Dacumos, Jin Xue, Eric F. Morand

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus

    Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus gan Eric F. Morand, Gabriel Abreu, Richard Furie, Vera Golder, Raj Tummala

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Advances in the management of systemic lupus erythematosus

    Advances in the management of systemic lupus erythematosus gan Eric F. Morand, Ruth Fernandez‐Ruiz, Ashira Blazer, Timothy B. Niewold

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Clinical associations of serum interleukin-17 in systemic lupus erythematosus

    Clinical associations of serum interleukin-17 in systemic lupus erythematosus gan Fabien B. Vincent, Melissa Northcott, Alberta Hoi, Fabienne Mackay, Eric F. Morand

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort

    Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort gan Kok-Hooi Yap, Melissa Northcott, Alberta Hoi, Eric F. Morand, Mandana Nikpour

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: <i>post-hoc</i> analysis of the Phase IIb MUSE trial of anifrolumab

    Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: <i>post-hoc</i> analysis of the Phase IIb MUSE trial of anifro... gan Eric F. Morand, Teodora Trasieva, Anna Berglind, Gabor G. Illei, Raj Tummala

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al’ by Isenberg

    Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MU... gan Eric F. Morand, Teodora Trasieva, Anna Berglind, Gabor G. Illei, Raj Tummala

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids

    Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids gan Leilani L. Santos, Pamela Hall, Christine N. Metz, Richard Bucala, Eric F. Morand

    Cyhoeddwyd 2001
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

    MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus gan Tali Lang, Andrew Foote, Jacinta P. W. Lee, Eric F. Morand, James Harris

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Independent association of glucocorticoids with damage accrual in SLE

    Independent association of glucocorticoids with damage accrual in SLE gan Diane Apostolopoulos, Rangi Kandane‐Rathnayake, Sudha Raghunath, Alberta Hoi, Mandana Nikpour, Eric F. Morand

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Perspectives of Patients With Rheumatic Diseases in the Early Phase of <scp>COVID</scp>‐19

    Perspectives of Patients With Rheumatic Diseases in the Early Phase of <scp>COVID</scp>‐19 gan Anna Antony, Kathryn Connelly, Thilinie De Silva, Laura Eades, William Tillett, Sally Ayoub, Eric F. Morand

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Patterns and prevalence of cognitive dysfunction in systemic lupus erythematosus

    Patterns and prevalence of cognitive dysfunction in systemic lupus erythematosus gan Sudha Raghunath, Yifat Glikmann‐Johnston, Fabien B. Vincent, Eric F. Morand, Julie C. Stout, Alberta Hoi

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus

    Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus gan Jack Godsell, Ina Rudloff, Rangi Kandane‐Rathnayake, Alberta Hoi, Marcel F. Nold, Eric F. Morand, James Harris

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: